chinese ipo

China’s IPO approval officers bestowed unbridled power

The process of gaining approval to list in China is open to corruption as a small number of officers have unchecked power over which applicants go first, economist says.
<div style="text-align: left;">
Guo Shuqing has publicly questioned China’s tedious listing approvals process since he became chairman of the CSRC in late 2011 (Imaginechina)</div>
<div style="text-align: left;"> Guo Shuqing has publicly questioned China’s tedious listing approvals process since he became chairman of the CSRC in late 2011 (Imaginechina)</div>

China’s securities regulator has long been a gatekeeper of new equity listings through its listing approval process, but the approving officers are bestowed so much unbridled power that issuers end up paying for the privilege to go public.

The IPO approval system is something China Securities Regulatory Commission CSRC needs to reform urgently, noted Minggao Shen, Greater China economist at Citi. “The procedure with only a small group of people reviewing listing applications causes many problems,” he said.

“IPO approving officers have unchecked, unbridled absolute power the system brews corruption,” he added.

The Public Offering Review Committee, a powerful arm of the CSRC...

¬ Haymarket Media Limited. All rights reserved.

FinanceAsia has updated its subscription model.

Registered readers now have the opportunity to read 5 articles from our award-winning website for free.

To obtain unlimited access to our award-winning exclusive news and analysis, we offer subscription packages, including single user, team subscription (2-5 users), or office-wide licences.

To help you and your colleagues access our proprietary content, please contact us at [email protected], or +(852) 2122 5222

Article limit is reached.

Hello! You have used up all of your free articles on FinanceAsia.

To obtain unlimited access to our award-winning exclusive news and analysis, we offer subscription packages, including single user, team subscription (2-5 users), or office-wide licences. To help you and your colleagues access our proprietary content, please contact us at [email protected], or +(852) 2122 5222